[DOI] [PMC free article] [PubMed] [Google Scholar] 363.Wolfson, B., Eades, G
Earlier this month, Novo Nordisk slashed Wegovy prices by up to 37% across dosages, a crucial strategic move by the drug major that has so far been unable to see a significant uptick vis-a-vis rival Mounjaro (tirzepatide) from Eli Lilly in the sale of its weight-loss injectable in India
None of that was immediately alarming on its own
Yes, many users report fat loss in stubborn areas like the midsection
Available online at: Summary Keywords weight loss, nutrient intake, glucagon-like peptide-1 receptor agonists, nutrition, diet, dietary reference intakes Citation Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water